Press Releases

FEBRUARY 4, 2026 — CRN today expressed strong support for the introduction of the Dietary Supplement Regulatory Uniformity Act by Congressman Nick Langworthy (R-NY-23), legislation that reaffirms the U.S. Food and Drug Administration’s (FDA) authority as the national regulator of dietary supplements.

FEBRUARY 3, 2026 — CRN today reiterated its opposition to Hawaii Senate Bill 2106 (SB 2106), legislation that would prohibit the sale of certain weight management and muscle-building dietary supplements to individuals under the age of 18 and further demand that retailers restrict all consumers’ access to these products by removing them from any self-service display.

JANUARY 15, 2026 — CRN today welcomed the introduction of the Dietary Supplement Listing Act of 2026 by U.S. Senator Dick Durbin (D-IL), marking a significant milestone in CRN’s years-long effort to modernize oversight of the dietary supplement marketplace through a federal dietary supplement registry.

JANUARY 14, 2026 — CRN today announced new member companies following approval by its board of directors during its quarterly meeting in December, advancing supplement ingredient science and distribution, women’s health, clinical research, and regulatory compliance.

JANUARY 7, 2026 — CRN today applauded the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) for recognizing the role dietary supplements can play in helping Americans meet nutrient needs in the newly released 2025–2030 Dietary Guidelines for Americans.

DECEMBER 17, 2025 — CRN today announced results of its recent Board of Directors elections, effective in January 2026.

DECEMBER 11, 2025 — CRN today commended the U.S. Food and Drug Administration (FDA) and expressed the association’s appreciation for FDA providing needed clarity on the placement of the Dietary Supplement Health and Education Act (DSHEA) disclaimer on product labels.

NOVEMBER 20, 2025 — The CRN Foundation today announced the release of CRN’s updated Vitamin K2 (menaquinone-7, MK-7) chapter as part of the Vitamin & Mineral Safety, 4th Edition (VMS4). For the first time, CRN’s rigorous safety evaluation establishes a supplemental Highest Observed Intake (HOI) level of 375 µg/day for adults, offering essential new guidance for manufacturers, regulators, and health practitioners seeking evidence-based recommendations for this increasingly used nutrient.

NOVEMBER 13, 2025 — CRN expressed disappointment today after the U.S. Court of Appeals for the Second Circuit declined to grant a preliminary injunction to pause enforcement of a New York law restricting the sale of certain dietary supplements to individuals under 18.

OCTOBER 17, 2025 — CRN today announced the publication of three new and updated chapters in its Vitamin & Mineral Safety, Fourth Edition (VMS4) series—expanding the supplement industry’s most comprehensive, science-based resource on nutrient safety.